Legend Biotech Corporation
Summary
Legend Biotech Corporation is registered in the Cayman Islands and entered in the “Registry of Companies” under number HL-300159. Its legal form is company limited by shares (Ltd). According to GLEIF, its ultimate parent is Genscript Biotech Corporation (Cayman Islands), which is also its direct parent. That group has 2 subsidiaries with LEIs in 1 country, 2 of them in the Cayman Islands. The LEI was first issued on 4 Sep 2020 and the record was last updated on 15 Jan 2025. It has lapsed: renewal was due by 15 Jan 2025. GLEIF's ISIN mapping lists 2 ISINs for this LEI. AssetCensus found 2 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 15 Jan 2025 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent relationship record was not renewed; it was last updated on 15 Jan 2025.
Company details
| Legal form | company limited by shares (Ltd) |
|---|---|
| Register | Registry of Companies · Register website |
| Registration number | HL-300159 |
| Registration authority | General Registry |
| Jurisdiction | Cayman Islands |
| Registered address | PO Box 10240, Harbour Place, KY1-1002 George Town, Cayman Islands |
| Headquarters address | 2101 Cottontail Lane, 08873 Somerset, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 27 May 2015 |
| LEI | 254900EIUFZTW136H859 |
| LEI status | lapsed |
| LEI first issued | 4 Sep 2020 |
| LEI record last updated | 15 Jan 2025 |
| Next LEI renewal | 15 Jan 2025 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Genscript Biotech Corporation | Genscript Biotech Corporation |
| Accounting period | 27 May 2015 to 1 Jan 2040 | 27 May 2015 to 1 Jan 2040 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Consolidation percentage reported to GLEIF | 100.00% | 100.00% |
| Relationship start | 27 May 2015 | 27 May 2015 |
| Recorded at GLEIF since | 4 Sep 2020 | 4 Sep 2020 |
| Last updated | 15 Jan 2025 | 15 Jan 2025 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (1)
- Probio Technology Limited Cayman Islands
ISINs mapped to this LEI (2)
US52490G1022 · US52490G2012
2 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.